Cambria Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Cambria Investment Management's BMY Position: Q2 2026 in Review
Cambria Investment Management increased its Bristol-Myers Squibb (BMY) stake by 23% in Q2 2026, buying an estimated $104K and bringing the position to 9,573 shares worth $552K. The position accounts for 0.03% of the portfolio, ranked #493.
Cambria Investment Management first reported a position in BMY in Q2 2015 and has held it in 3 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Cambria Investment Management held 9,573 shares of Bristol-Myers Squibb worth $552K as of Q2 2026.
- Cambria Investment Management bought 1,809 Bristol-Myers Squibb shares in Q2 2026, an estimated $104K.
- Bristol-Myers Squibb made up 0.03% of Cambria Investment Management's portfolio in Q2 2026, its #493 holding.
- Cambria Investment Management first reported a position in Bristol-Myers Squibb in Q2 2015 and has held it in 3 quarters since.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Cambria Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.